HK1198646A1 - Substituted imidazopyridines and the use thereof - Google Patents
Substituted imidazopyridines and the use thereofInfo
- Publication number
- HK1198646A1 HK1198646A1 HK14112109.7A HK14112109A HK1198646A1 HK 1198646 A1 HK1198646 A1 HK 1198646A1 HK 14112109 A HK14112109 A HK 14112109A HK 1198646 A1 HK1198646 A1 HK 1198646A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- substituted imidazopyridines
- imidazopyridines
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/5025—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102011075398A DE102011075398A1 (de) | 2011-05-06 | 2011-05-06 | Substituierte Imidazopyridazine und ihre Verwendung |
PCT/EP2012/058048 WO2012152630A1 (de) | 2011-05-06 | 2012-05-02 | Substituierte imidazopyridazine und ihre verwendung |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1198646A1 true HK1198646A1 (en) | 2015-05-22 |
Family
ID=46197232
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK14112109.7A HK1198646A1 (en) | 2011-05-06 | 2014-12-02 | Substituted imidazopyridines and the use thereof |
Country Status (8)
Country | Link |
---|---|
US (1) | US9150580B2 (de) |
EP (1) | EP2705038A1 (de) |
JP (1) | JP6100756B2 (de) |
CN (1) | CN103842363B (de) |
CA (1) | CA2834903A1 (de) |
DE (1) | DE102011075398A1 (de) |
HK (1) | HK1198646A1 (de) |
WO (1) | WO2012152630A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112015012571B1 (pt) | 2012-11-30 | 2022-05-24 | Astellas Pharma Inc | Compostos de imidazopiridina e usos terapêuticos dos mesmos |
WO2015106268A1 (en) | 2014-01-13 | 2015-07-16 | Ironwood Pharmaceuticals, Inc. | USE OF sGC STIMULATORS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS |
US20180169095A1 (en) | 2015-05-06 | 2018-06-21 | Bayer Pharma Aktiengesellschaft | The use of sgc stimulators, sgc activators, alone and combinations with pde5 inhibitors for the treatment of digital ulcers (du) concomitant to systemic sclerosis (ssc) |
DK3325013T4 (da) | 2015-07-23 | 2023-10-16 | Bayer Pharma AG | Stimulatorer og/eller aktivatorer af den opløselige guanylatcyklase (sgc) i kombination med en inhibitor af den neutrale endopeptidase (nep inhibitor) og en angiotensin aii-antagonist og deres anvendelse |
CN108463224A (zh) | 2015-12-14 | 2018-08-28 | 铁木医药有限公司 | sGC刺激剂用于胃肠功能障碍治疗的应用 |
CN109890379A (zh) | 2016-10-11 | 2019-06-14 | 拜耳制药股份公司 | 包含sGC活化剂和盐皮质激素受体拮抗剂的组合产品 |
EP3525779B1 (de) | 2016-10-11 | 2024-06-05 | Bayer Pharma Aktiengesellschaft | Kombination enthaltend den sgc stimulator vericuguat und den mineralcorticoid-rezeptor-antagonist finerenone |
WO2018111795A2 (en) | 2016-12-13 | 2018-06-21 | Ironwood Pharmaceuticals, Inc. | Use of sgc stimulators for the treatment of esophageal motility disorders |
EP3609883B1 (de) | 2017-04-11 | 2022-06-29 | Sunshine Lake Pharma Co., Ltd. | Fluorsubstituierte indazolverbindungen und verwendungen davon |
BR112020022340A2 (pt) | 2018-05-15 | 2021-02-02 | Bayer Aktiengesellschaft | benzamidas substituídas por 1,3-tiazol-2-il para o tratamento de doenças associadas com sensibilização de fibras nervosas |
EP3820476A1 (de) | 2018-07-11 | 2021-05-19 | Cyclerion Therapeutics, Inc. | Verwendung von sgc-stimulatoren zur behandlung von mitochondrialen erkrankungen |
WO2020164008A1 (en) | 2019-02-13 | 2020-08-20 | Bayer Aktiengesellschaft | Process for the preparation of porous microparticles |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19642255A1 (de) | 1996-10-14 | 1998-04-16 | Bayer Ag | Verwendung von 1-Benzyl-3-(substituierten-hetaryl) -kondensierten Pyrazol-Derivaten |
DE19834044A1 (de) | 1998-07-29 | 2000-02-03 | Bayer Ag | Neue substituierte Pyrazolderivate |
DE10220570A1 (de) | 2002-05-08 | 2003-11-20 | Bayer Ag | Carbamat-substituierte Pyrazolopyridine |
SI1869049T1 (sl) * | 2005-03-21 | 2009-08-31 | Lilly Co Eli | Spojine imidazopiridazina |
DE102006043443A1 (de) * | 2006-09-15 | 2008-03-27 | Bayer Healthcare Ag | Neue aza-bicyclische Verbindungen und ihre Verwendung |
CN101981033B (zh) * | 2008-02-06 | 2015-02-04 | 百时美施贵宝公司 | 用作激酶抑制剂的取代的咪唑并哒嗪化合物 |
AU2009322836B2 (en) | 2008-11-25 | 2013-04-04 | Merck Sharp & Dohme Corp. | Soluble guanylate cyclase activators |
DE102009004245A1 (de) * | 2009-01-09 | 2010-07-15 | Bayer Schering Pharma Aktiengesellschaft | Neue anellierte, Heteroatom-verbrückte Pyrazol- und Imidazol-Derivate und ihre Verwendung |
WO2011119518A1 (en) * | 2010-03-25 | 2011-09-29 | Merck Sharp & Dohme Corp. | Soluble guanylate cyclase activators |
-
2011
- 2011-05-06 DE DE102011075398A patent/DE102011075398A1/de not_active Withdrawn
-
2012
- 2012-05-02 EP EP12724584.3A patent/EP2705038A1/de not_active Withdrawn
- 2012-05-02 CN CN201280033522.0A patent/CN103842363B/zh not_active Expired - Fee Related
- 2012-05-02 WO PCT/EP2012/058048 patent/WO2012152630A1/de active Application Filing
- 2012-05-02 US US14/115,871 patent/US9150580B2/en not_active Expired - Fee Related
- 2012-05-02 CA CA2834903A patent/CA2834903A1/en not_active Abandoned
- 2012-05-02 JP JP2014508788A patent/JP6100756B2/ja not_active Expired - Fee Related
-
2014
- 2014-12-02 HK HK14112109.7A patent/HK1198646A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
US9150580B2 (en) | 2015-10-06 |
EP2705038A1 (de) | 2014-03-12 |
CA2834903A1 (en) | 2012-11-15 |
CN103842363B (zh) | 2017-09-26 |
US20140113900A1 (en) | 2014-04-24 |
JP6100756B2 (ja) | 2017-03-22 |
CN103842363A (zh) | 2014-06-04 |
DE102011075398A1 (de) | 2012-11-08 |
WO2012152630A1 (de) | 2012-11-15 |
JP2014513113A (ja) | 2014-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1190710A1 (zh) | 氟烷基取代的吡唑並吡啶及其用途 | |
HK1198698A1 (en) | Substituted annellated pyrimidine and the use thereof | |
AP2014007731A0 (en) | Substituted triazolopyridines and their use as TTKinhibitors | |
HK1198646A1 (en) | Substituted imidazopyridines and the use thereof | |
GB201111705D0 (en) | Compounds and their use | |
HK1191034A1 (en) | N-carboxyalkyl-auristatins and use thereof n- | |
IL231082A (en) | Pyrimido compounds - pyridazinone and their use | |
GB201111630D0 (en) | Novel compounds and their use | |
EP2697386A4 (de) | Pepducin-entwurf und -verwendung | |
GB201114448D0 (en) | Compounds and their use | |
GB201004886D0 (en) | The Hoppon | |
GB201115344D0 (en) | The FitCase | |
HK1198587A1 (en) | Isothiazolopyridine-2-carboxamides and their use as pharmaceuticals -2- | |
GB201009016D0 (en) | The SealCase | |
GB201115921D0 (en) | The Denness fast-loo | |
GB201018845D0 (en) | The gauntlag | |
GB2497001B (en) | The hand | |
GB201204735D0 (en) | The quadtrolley | |
GB201104444D0 (en) | Compounds and their use | |
GB201120676D0 (en) | The degravitator | |
GB201112500D0 (en) | The degravitator | |
GB201112308D0 (en) | The degravitator | |
GB201110618D0 (en) | The gilabead | |
GB201110314D0 (en) | The lughole | |
GB201108973D0 (en) | The fledge |